VOLAKHAVA, Anastasiya, Šárka PAVLOVÁ, Kristýna ZÁVACKÁ, Karol PÁL, Marcela KRZYŽÁNKOVÁ, Hana SYNÁČKOVÁ, Šárka POSPÍŠILOVÁ, Ilgar MAMEDOV and Karla PLEVOVÁ. Hide and seek retroelement activity in hematological malignancies. In EMBL Conference Cancer Genomics 2023, Heidelberg, Německo. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Hide and seek retroelement activity in hematological malignancies.
Authors VOLAKHAVA, Anastasiya, Šárka PAVLOVÁ, Kristýna ZÁVACKÁ, Karol PÁL, Marcela KRZYŽÁNKOVÁ, Hana SYNÁČKOVÁ, Šárka POSPÍŠILOVÁ, Ilgar MAMEDOV and Karla PLEVOVÁ.
Edition EMBL Conference Cancer Genomics 2023, Heidelberg, Německo, 2023.
Other information
Original language English
Type of outcome Konferenční abstrakta
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Organization Středoevropský technologický institut – Repository – Repository
Keywords in English Retroelements; Long Interspersed Nucleic Elements; chronic lymphocytic leukemia
Links LX22NPO5102, research and development project.
Changed by Changed by: RNDr. Daniel Jakubík, učo 139797. Changed: 28/3/2024 04:03.
Abstract
Retroelements (REs), which function via a “copy-and-paste” mechanism, comprise nearly half of the human genome. The Long Interspersed Nucleic Elements, type 1 (LINE-1 or L1) are the only active autonomous REs. They are able to retrotranspose other RNAs including Alu and SVA REs, and occasionally protein-coding RNAs. Retroelements are silenced via multiple mechanisms, but genomic instability of cancer cells often leads to aberrant disruption of RE repression and enhances their transposition activity. The main goal of our research is to explore RE activity in chronic lymphocytic leukemia (CLL) and myelodysplastic syndrome (MDS) and to study the impact of therapy and TP53 inactivation on RE activity. To identify tumor-specific RE insertions, we adopted a highly sensitive amplicon NGS protocol for localizing insertions of REs from Alu-Ya5, Alu-Yb8, or L1-HS families into their target genomic regions. In total, 99 samples from 17 MDS and 21 CLL patients, and 60 samples from 4 leukemic cell lines were analyzed.
Type Name Uploaded/Created by Uploaded/Created Rights
CancerGenomics2023_EMBL_Abstract_Book_-_FINAL__1_.pdf Licence Creative Commons  File version 27/3/2024

Properties

Name
CancerGenomics2023_EMBL_Abstract_Book_-_FINAL__1_.pdf
Address within IS
https://repozitar.cz/auth/repo/60429/1709307/
Address for the users outside IS
https://repozitar.cz/repo/60429/1709307/
Address within Manager
https://repozitar.cz/auth/repo/60429/1709307/?info
Address within Manager for the users outside IS
https://repozitar.cz/repo/60429/1709307/?info
Uploaded/Created
Wed 27/3/2024 04:12

Rights

Right to read
  • anyone on the Internet
Right to upload
 
Right to administer:
  • a concrete person RNDr. Daniel Jakubík, uco 139797
  • a concrete person Mgr. Eva Zárybnická, DiS., uco 206552
  • a concrete person Mgr. Jolana Surýnková, uco 220973
  • a concrete person Mgr. Michal Maňas, uco 2481
Attributes
 
Print
Add to clipboard Displayed: 19/5/2024 13:13